Cargando…
Schistosoma mansoni Sirtuins: Characterization and Potential as Chemotherapeutic Targets
BACKGROUND: The chemotherapy of schistosomiasis currently depends on the use of a single drug, praziquantel. In order to develop novel chemotherapeutic agents we are investigating enzymes involved in the epigenetic modification of chromatin. Sirtuins are NAD+ dependent lysine deacetylases that are i...
Autores principales: | Lancelot, Julien, Caby, Stéphanie, Dubois-Abdesselem, Florence, Vanderstraete, Mathieu, Trolet, Jacques, Oliveira, Guilherme, Bracher, Franz, Jung, Manfred, Pierce, Raymond J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3772001/ https://www.ncbi.nlm.nih.gov/pubmed/24069483 http://dx.doi.org/10.1371/journal.pntd.0002428 |
Ejemplares similares
-
Analysis of the interactome of Schistosoma mansoni histone deacetylase 8
por: Caby, Stéphanie, et al.
Publicado: (2017) -
Dual Targeting of Insulin and Venus Kinase Receptors of Schistosoma mansoni for Novel Anti-schistosome Therapy
por: Vanderstraete, Mathieu, et al.
Publicado: (2013) -
Histone deacetylase 8 interacts with the GTPase SmRho1 in Schistosoma mansoni
por: Pagliazzo, Lucile, et al.
Publicado: (2021) -
Structural Basis for the Inhibition of Histone Deacetylase 8 (HDAC8), a Key Epigenetic Player in the Blood Fluke Schistosoma mansoni
por: Marek, Martin, et al.
Publicado: (2013) -
Fast evolutionary rates associated with functional loss in class I glucose transporters of Schistosoma mansoni
por: Cabezas-Cruz, Alejandro, et al.
Publicado: (2015)